Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hepatitis C

Free Subscription 14.10.2019 1 Biochem Biophys Res Commun 1 Eur J Gastroenterol Hepatol 1 J Hepatol 2 J Med Virol 2 J Viral Hepat 1 J Virol 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Biochem Biophys Res Commun

1. KANDANGWA M, Liu Q
   HCV NS5A hyperphosphorylation is involved in viral translation modulation.
   Biochem Biophys Res Commun. 2019 Oct 1. pii: S0006-291X(19)31841.
   PubMed     Text format     Abstract available
   
   

   
   Eur J Gastroenterol Hepatol

2. WIEGAND J, Buggisch P, Mauss S, Boeker KHW, et al
   Hepatitis C therapy with direct antiviral agents in patients with advanced chronic kidney disease: real-world experience of the German Hepatitis C-Registry (Deutsches Hepatitis C-Register).
   Eur J Gastroenterol Hepatol. 2019;31:1424-1431.
   PubMed     Text format     Abstract available
   
   

   
   J Hepatol

3. VRANCKEN B, Cuypers L, Perez AB, Chueca N, et al
   Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmes.
   J Hepatol. 2019 Oct 1. pii: S0168-8278(19)30476.
   PubMed     Text format    
   
   

   
   J Med Virol

4. TSAI TC, Deng ST, Hsu CW
   The efficacy and safety of elbasvir/grazoprevir treatment in HCV genotype 1 patients in Taiwan.
   J Med Virol. 2019 Oct 10. doi: 10.1002/jmv.25605.
   PubMed     Text format     Abstract available
   
   
5. SAITO Y, Imamura M, Uchida T, Osawa M, et al
   Ribavirin induces hepatitis C virus genome mutations in chronic hepatitis patients who failed to respond to prior daclatasvir plus asunaprevir therapy.
   J Med Virol. 2019 Oct 4. doi: 10.1002/jmv.25602.
   PubMed     Text format     Abstract available
   
   

   
   J Viral Hepat

6. PINTILIE H, Brook G
   Commentary: A review of risk of hepatitis B and C transmission through biting or spitting.
   J Viral Hepat. 2018 Jul 26. doi: 10.1111/jvh.12976.
   PubMed     Text format     Abstract available
   
   
7. RUSSO FP, Zanetto A, Gambato M, Bortoluzzi I, et al
   Hepatitis C virus eradication with direct acting antiviral improves insulin resistance.
   J Viral Hepat. 2019 Oct 9. doi: 10.1111/jvh.13215.
   PubMed     Text format     Abstract available
   
   

   
   J Virol

8. WU MJ, Shanmugam S, Welsch C, Yi M, et al
   Palmitoylation of the hepatitis C virus NS2 regulates its subcellular localization and NS2-NS3 autocleavage.
   J Virol. 2019 Oct 9. pii: JVI.00906-19. doi: 10.1128/JVI.00906.
   PubMed     Text format     Abstract available
   
   

   
   PLoS One

9. GARCIA A, Moore Boffi S, Gayet-Ageron A, Vernaz N, et al
   Access to unauthorized hepatitis C generics: Perception and knowledge of physicians, pharmacists, patients and non-healthcare professionals.
   PLoS One. 2019;14:e0223649.
   PubMed     Text format     Abstract available
   
   
10. RAYAN DA'AS S, Azzeh M
    Subgenotyping and genetic variability of hepatitis C virus in Palestine.
    PLoS One. 2019;14:e0222799.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis C is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: